Nemera’s takes dermal treatments to millions of patients
Bioscience Today’s latest issue features Nemera’s article on how we strike the perfect balance of ensuring safety of our dermal drug delivery devices whilst fulfilling regulatory requirements and patient needs.
Read more from our Category Managers Audrey Chandra and Raphaele Audibert.
Nemera has been working in the dermal field for the past two decades and produces airless devices used by some of the biggest pharmaceutical companies in the world to ultimately serve patients’ needs, and is today leading the systemic transdermal gel and cream market.
The first treatment launched with a Nemera device was for cold sores, and today millions of patients rely on its precise delivery systems for a wide range of topical and systemic conditions in the dermal drug delivery field alone.
One of the biggest breakthroughs has been the airless device designed by the Nemera team, Sof’Bag®.
Sof’Bag® is composed of an aluminium based pouchinside a bottle surrounded by a metered pump dispenser. It is designed with several features: the part containing the formulation, the pouch, protects it from oxidation, light and humidity. These elements can sometimes alter the formulation and modify its efficacy if they are allowed.
Nemera provides an end-to-end service, which includes taking a product from early-stages concept, including human factors studies, to design and high scale manufacturing, the technical support needed in relation to filling the drug delivery devices, and supporting the submission of registration dossiers to the appropriate regulatory authorities. This holistic approach and integrated front-to-end services enable Nemera to innovate within every development phase of its products. Our ultimate goal is to foster patients’ adherence to their treatment and improve their quality of life.
The full article:
The full issue of the magazine:
Nemera is a world leader in the design, development, and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generics industries. Nemera offers a comprehensive portfolio of products and services across ophthalmology, nasal, inhalation, dermal, transdermal and parenteral delivery. Nemera’s vision is to be the most patient-centric drug delivery device company. Nemera always puts patients first, providing high-quality solutions that have a demonstrable impact on patients’ health
Nemera’s newly branded Insight Innovation Center, with offices in North America and Europe, provides consultative services to support your overall device strategy. Providing user research, Human Factors, User Experience design, and Design for manufacturing, the Insight Innovation Center can help customers navigate their device strategy for both novel and platform solutions. Users are at the center of everything that we do in our effort to always put patients first.